réseau européen sur la prévention du sida et de l'hépatite en milieu carcéral

The ORS PACA proposes to distribute the publications of this network.
For this purpose we would like you to indicate the following information in the form:

Your data
Your choice of publications

Remark: all publications are without charge - but we will ask for a contribution to the mailing cost.

ENTER YOUR DATA:

NAME:
First name:
Address:
E-mail:
Phone:
Fax:

ENTER YOUR CHOICE

please cross the publication you wish to receive:

Publications and Presentation of Network Members in 1997/1998

A survey of bloodborne viruses and associated risk behaviours in Greek prisons.
Malliori, M, Sypsa, V, Psichogiou, M, Touloumi, G, Skoutelis, A, Tassopoulos, N, Hatzakis, A, Stefanis, A. Addiction (1998) 93(2), 243-251.

European Network on HIV/AIDS and Hepatitis Prevention in Prisons.
Annual Report May 1998.

Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
Bird AG. Gore SM. Hutchinson SJ. Lewis SC. Cameron S. Burns S. British Medical Journal 1997;315(7099):21-4.

Heterosexual intercourses in prison.
Rotily M, Gore S, Weilandt C. Sexually Transmitted Diseases ; April 1998, Vol 25 n°4:217.

HIV seroprevalence, injecting drug use and sexual behaviours among European prisoners : a multicenter study .
Rotily M, Weilandt C, Gore S, Kall K, van Haastrecht JA, Iandolo E, De Jong W, Rousseau S. AIDS (submitted)

Interferon-a2b Therapy in Low-Activity Hepatitis C: A pilot study.
Nordøy I, Krarup PB, Bell H, Christensen PB, Elgjo K, Von Der Lippe B, Schaffalitzky De Muchadell O, Mæland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E: Scand J Gastroenterol: 1997: 32: 1256-60.

L’infection à VIH en milieu carcéral : épidémiologie, prévention et aspects juridiques.
Actes du Séminaire du 21-22 juin 1996.

Le risque de transmission des virus du Sida et des hépatites en milieu carcéral : une approche épidémiologique.
Rotily M. Delorme C, Ben Diane MK. Cahiers de Sécurité Intérieure 1998; 31: 195-210

Prävalenz HIV-bezogenen Risikoverhaltens im Justizvollzug - Ergebnisse einer Machbarkeitsstudie.
Weilandt. Infektionsepidemiologigische Forschung, 2/97, 1997

Prävalenz viraler Infektionskrankheiten und infektionsrelevanten Risikoverhaltens im deutschen Justizvollzug.
Stöver,H, Weilandt C,. Infektionsepidemiologische Forschung, II/97, S. 22-27.

Prevalence of HIVand injecting drug use in men entering Liverpool prison.
Bellis MA, Weild AR, Beeching NJ, Mutton KJ & Syed Q. British Medical Journal 1997; 315:30-31.

Prevention of HIV-Infection in Prisons: A European Network.
Weilandt, C, Rotily, M In: AIDS Education-Interventions in Multi-Cultural Societes, I. Schenker, G. Sabar-Friedmann, FS by, 1996, 173-177. Plenum Press: New York.

Salivscreening för HIV på fängelse visade inga okända fall (Saliva screening for HIV in a prison showed no new cases).
Käll K, Thorstensson R. Läkartidningen (Journal of the Swedish Medical Association), 4 (4), 1998, 44-45.

Sida et Prison.
Hariga, F. Agence de Prevention du Sida. Ministère de la Santé et de la Communauté francaise de Belgique. 1997.

After having filled in this form please
don't forget to press the following bottom:

Or, if you made an error,
the next bottom: